NUCLEOLIN and neuroblastoma: Altogether, these results demonstrate that cell surface NCL is expressed by NB cells, representing a potential marker and a targetable antigen for NB tumors, and supporting the rationale for pre-clinical evaluation of cell surface NCL-targeted therapy in NB.